Marthe Lvf
Marthe Lvf
Affiliazione sconosciuta
Email verificata su rr-research.no
Titolo
Citata da
Citata da
Anno
Multifocal primary prostate cancer exhibits high degree of genomic heterogeneity
M Lvf, S Zhao, U Axcrona, B Johannessen, AC Bakken, KT Carm, ...
European urology 75 (3), 498-505, 2019
542019
Novel 5′ fusion partners of ETV1 and ETV4 in prostate cancer
JD Barros-Silva, P Paulo, AC Bakken, N Cerveira, M Lvf, R Henrique, ...
Neoplasia 15 (7), 720-IN6, 2013
402013
A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis
RI Skotheim, GOS Thomassen, M Eken, GE Lind, F Micci, FR Ribeiro, ...
Molecular cancer 8 (1), 1-9, 2009
332009
PBX3 is a putative biomarker of aggressive prostate cancer
H Ramberg, HH Grytli, S Nygrd, W Wang, O gren, S Zhao, M Lvf, ...
International journal of cancer 139 (8), 1810-1820, 2016
272016
Fusion gene microarray reveals cancer type‐specificity among fusion genes
M Lvf, GOS Thomassen, AC Bakken, R Celestino, T Fioretos, GE Lind, ...
Genes, Chromosomes and Cancer 50 (5), 348-357, 2011
212011
Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes
R Celestino, E Sigstad, M Lvf, GOS Thomassen, KK Grholt, ...
Genes, Chromosomes and Cancer 51 (12), 1154-1164, 2012
192012
Novel RNA variants in colorectal cancers
AM Hoff, B Johannessen, S Alagaratnam, S Zhao, T Nome, M Lvf, ...
Oncotarget 6 (34), 36587, 2015
152015
Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer
KT Carm, AM Hoff, AC Bakken, U Axcrona, K Axcrona, RA Lothe, ...
Scientific reports 9 (1), 1-6, 2019
142019
A novel transcript, VNN1‐AB, as a biomarker for colorectal cancer
M Lvf, T Nome, J Bruun, M Ekns, AC Bakken, JP Mpindi, S Kilpinen, ...
International journal of cancer 135 (9), 2077-2084, 2014
132014
Novel transcription-induced fusion RNAs in prostate cancer
S Zhao, M Lvf, KT Carm, AC Bakken, AM Hoff, RI Skotheim
Oncotarget 8 (30), 49133, 2017
62017
Assessment of fusion gene status in sarcomas using a custom made fusion gene microarray
M Lvf, GOS Thomassen, F Mertens, N Cerveira, MR Teixeira, RA Lothe, ...
PloS one 8 (8), e70649, 2013
42013
Molecular research on localized prostate cancer needs to take inter-focal heterogeneity into account
EJK Axcrona, M Lvf, KT Carm, B Johanessen, AC Bakken, A Hoff, ...
European Urology Supplements 18 (1), e340, 2019
2019
PO-311 Multifocality complicates molecular classification of primary prostate cancer
K Carm, S Zhao, AC Bakken, B Johannessen, AM Hoff, U Axcrona, ...
ESMO Open 3, A142, 2018
2018
Abstracts from the 3rd Conference on Aneuploidy and Cancer: Clinical and Experimental Aspects
A Cornish-Bowden, D Rasnick, HH Heng, S Horne, B Abdallah, G Liu, ...
Molecular Cytogenetics 10 (2), 77-94, 2017
2017
Multifocal prostate cancer has high degree of genomic heterogeneity
M Lvf, S Zhao, U Axcrona, B Johannesen, AM Hoff, AC Bakken, KT Carm, ...
Cancer Research 77 (13 Supplement), 1745-1745, 2017
2017
2570 Identification of novel chimeric RNAs which are overexpressed in prostate cancer
M Lvf, S Zhao, RI Skotheim
European Journal of Cancer 3 (51), S501, 2015
2015
Cancer specific transcript variants
RI Skotheim, GE Lind, RA Lothe, M Eken, GOS Thomassen
US Patent App. 13/139,033, 2012
2012
Cancer specific transcript variants
RI Skotheim, GE Lind, RA Lothe, M Eken, GOS Thomassen
US Patent App. 13/139,033, 2012
2012
Cancer specific transcript variants
RI Skotheim, GE Lind, RA Lothe, M Eken, GOS Thomassen
US Patent App. 13/139,033, 2012
2012
791 An oligo microarray design for detection of known and putative oncogenic fusion transcripts
M Lvf, GOS Thomassen, GE Lind, RA Lothe, RI Skotheim
ejc supplements 5 (8), 199, 2010
2010
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20